Is intra-arterial chemotherapy useful in high-grade gliomas?

Umberto Basso, Sara Lonardi, Alba A. Brandes

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Low delivery of common chemotherapeutic drugs to the brain is considered to be a major obstacle for obtaining durable disease control in patients with high-grade gliomas. Intra-arterial drug injection after selective catheterization of cerebral arteries has been performed in some small clinical trials in order to achieve higher drug concentration in the tumor while minimizing systemic exposure. We reviewed the results in terms of response and toxicity from studies with intra-arterial administration of nitrosoureas and platinum derivatives, as well as the principal aspects and perspectives of the new strategy of blood-brain barrier disruption with osmotic agents or bradykinin analogs. No superiority of intra-arterial chemotherapy over its intravenous counterpart has been demonstrated so far and although the incidence of serious neurotoxicity is reduced, the risk of untoward acute complication still contraindicates internal carotid or vertebral artery catheterization for chemotherapy administration outside the setting of well-controlled clinical trials.

Original languageEnglish
Pages (from-to)507-519
Number of pages13
JournalExpert Review of Anticancer Therapy
Volume2
Issue number5
Publication statusPublished - Oct 2002

Fingerprint

Glioma
Drug Therapy
Catheterization
Pharmaceutical Preparations
Intra-Arterial Injections
Cerebral Arteries
Vertebral Artery
Controlled Clinical Trials
Internal Carotid Artery
Bradykinin
Platinum
Blood-Brain Barrier
Clinical Trials
Incidence
Brain
Neoplasms

Keywords

  • Blood-brain barrier
  • High-grade glioma
  • Intra-arterial chemotherapy
  • Mannitol
  • RMP-7

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

Is intra-arterial chemotherapy useful in high-grade gliomas? / Basso, Umberto; Lonardi, Sara; Brandes, Alba A.

In: Expert Review of Anticancer Therapy, Vol. 2, No. 5, 10.2002, p. 507-519.

Research output: Contribution to journalArticle

@article{9021b047016c48ff8e8aecec75bc88d0,
title = "Is intra-arterial chemotherapy useful in high-grade gliomas?",
abstract = "Low delivery of common chemotherapeutic drugs to the brain is considered to be a major obstacle for obtaining durable disease control in patients with high-grade gliomas. Intra-arterial drug injection after selective catheterization of cerebral arteries has been performed in some small clinical trials in order to achieve higher drug concentration in the tumor while minimizing systemic exposure. We reviewed the results in terms of response and toxicity from studies with intra-arterial administration of nitrosoureas and platinum derivatives, as well as the principal aspects and perspectives of the new strategy of blood-brain barrier disruption with osmotic agents or bradykinin analogs. No superiority of intra-arterial chemotherapy over its intravenous counterpart has been demonstrated so far and although the incidence of serious neurotoxicity is reduced, the risk of untoward acute complication still contraindicates internal carotid or vertebral artery catheterization for chemotherapy administration outside the setting of well-controlled clinical trials.",
keywords = "Blood-brain barrier, High-grade glioma, Intra-arterial chemotherapy, Mannitol, RMP-7",
author = "Umberto Basso and Sara Lonardi and Brandes, {Alba A.}",
year = "2002",
month = "10",
language = "English",
volume = "2",
pages = "507--519",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Is intra-arterial chemotherapy useful in high-grade gliomas?

AU - Basso, Umberto

AU - Lonardi, Sara

AU - Brandes, Alba A.

PY - 2002/10

Y1 - 2002/10

N2 - Low delivery of common chemotherapeutic drugs to the brain is considered to be a major obstacle for obtaining durable disease control in patients with high-grade gliomas. Intra-arterial drug injection after selective catheterization of cerebral arteries has been performed in some small clinical trials in order to achieve higher drug concentration in the tumor while minimizing systemic exposure. We reviewed the results in terms of response and toxicity from studies with intra-arterial administration of nitrosoureas and platinum derivatives, as well as the principal aspects and perspectives of the new strategy of blood-brain barrier disruption with osmotic agents or bradykinin analogs. No superiority of intra-arterial chemotherapy over its intravenous counterpart has been demonstrated so far and although the incidence of serious neurotoxicity is reduced, the risk of untoward acute complication still contraindicates internal carotid or vertebral artery catheterization for chemotherapy administration outside the setting of well-controlled clinical trials.

AB - Low delivery of common chemotherapeutic drugs to the brain is considered to be a major obstacle for obtaining durable disease control in patients with high-grade gliomas. Intra-arterial drug injection after selective catheterization of cerebral arteries has been performed in some small clinical trials in order to achieve higher drug concentration in the tumor while minimizing systemic exposure. We reviewed the results in terms of response and toxicity from studies with intra-arterial administration of nitrosoureas and platinum derivatives, as well as the principal aspects and perspectives of the new strategy of blood-brain barrier disruption with osmotic agents or bradykinin analogs. No superiority of intra-arterial chemotherapy over its intravenous counterpart has been demonstrated so far and although the incidence of serious neurotoxicity is reduced, the risk of untoward acute complication still contraindicates internal carotid or vertebral artery catheterization for chemotherapy administration outside the setting of well-controlled clinical trials.

KW - Blood-brain barrier

KW - High-grade glioma

KW - Intra-arterial chemotherapy

KW - Mannitol

KW - RMP-7

UR - http://www.scopus.com/inward/record.url?scp=0036798089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036798089&partnerID=8YFLogxK

M3 - Article

C2 - 12382519

AN - SCOPUS:0036798089

VL - 2

SP - 507

EP - 519

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 5

ER -